Phileo by Lesaffre is a globally recognized leader in the field of animal health and nutrition, operating as a dedicated business unit of Lesaffre, a French family-owned group with over 170 years of fermentation expertise. Headquartered in Marcq-en-Barœul, France, Phileo’s mission is to improve animal health and performance through microbiota-centered solutions. The company leverages science-backed innovations in yeast and fermentation technologies to meet the growing global demand for sustainable animal farming.
Core Business
Phileo specializes in developing, producing, and marketing yeast-based probiotics, postbiotics, and other functional ingredients aimed at improving animal health, enhancing performance, and reducing antibiotic use. Their solutions support livestock species including poultry, swine, ruminants, and aquaculture.
Phileo’s product portfolio is built upon three major pillars:
- Yeast Probiotics: Live yeast such as Actisaf Sc 47 for gut health and performance enhancement.
- Yeast Postbiotics: Ingredients like Safmannan, which enhance immune responses and reduce pathogenic pressure.
- Yeast Derivatives: Products like Selsaf 3000, a source of organic selenium for oxidative stress management.
Product and Service Offerings
Phileo's major product categories include:
- Probiotics
- Actisaf Sc 47: A live yeast probiotic widely used in ruminants, swine, and poultry to improve gut flora, digestion, and feed conversion.
- Postbiotics
- Safmannan: A premium yeast fraction rich in mannan-oligosaccharides (MOS) and beta-glucans, known for immune modulation.
- Yeast Derivatives
- Selsaf 3000: A highly bioavailable organic selenium source for cellular protection and antioxidant support.
In addition to products, Phileo offers deep technical services, on-farm trials, microbiota research, and tailored nutritional advice for feed manufacturers, integrators, and farmers.
Specialisation and Core USP
Phileo’s core strength lies in its deep R&D infrastructure, supported by 10 research platforms, 60 scientific collaborations, and an extensive microbiota analysis capability. It is one of the few animal nutrition companies offering end-to-end microbiome analysis integrated into product development.
Their innovation is built on Lesaffre’s fermentation legacy, giving Phileo access to advanced biofermentation platforms and global production facilities. Their tailor-made programs for gut health, immunity, and feed efficiency make them a preferred partner in sustainable livestock solutions.
Financials
While Phileo does not publish standalone financials, Lesaffre, its parent company, reported €2.2 billion in revenue in 2023, with over 11,000 employees and operations in more than 80 countries. Phileo is one of the key business units contributing significantly to Lesaffre’s growth in the feed and animal care division.
Shipment and Export Records
According to global shipment tracking platforms like Volza and ImportYeti:
- Over 1,200 international shipments of Phileo products have been recorded between 2021 and 2024.
- Key export destinations include the United States, India, Brazil, Vietnam, and Germany.
- Frequent HS codes include 230990 (Animal Feed Preparations), highlighting their focus on feed additives.
Target Markets
Phileo operates in more than 100 countries, with a strong presence in:
- Asia-Pacific (especially India, Vietnam, China)
- Europe
- Latin America
- North America
Their primary customers include feed manufacturers, large integrators, and animal producers in poultry, swine, ruminants, and aquaculture sectors.
Capabilities
- Global R&D Centers: Including microbiota research labs and pilot-scale fermentation units.
- Production Footprint: Multiple GMP-certified plants across France, Mexico, and the United States.
- Technical Services Team: Over 100 nutritionists, veterinarians, and microbiologists for customer support.
Certifications and Compliance
Phileo's production and quality standards are aligned with:
- FAMI-QS Certification
- ISO 9001 and ISO 22000
- GMP+ Certification
- European Feed Additive Authorizations (EFSA-approved)
- Compliance with US FDA, USDA, and other regional regulatory frameworks
Customer Testimonials
From a customer review published by an Indian feed integrator:
"Phileo’s Actisaf Sc 47 helped us reduce FCR by 4% in our poultry operations. The technical support and consistency in product performance are unmatched."
Another European dairy farm manager notes:
"We’ve seen a significant reduction in subclinical acidosis since switching to Phileo’s yeast solutions. Their postbiotic solutions are truly next-gen."
Major Achievements
- Winner of Animal Pharm Award for Best Animal Health Product in the Probiotic Segment.
- Hosted Global Gut Health Conferences featuring 100+ industry experts.
- Launched the Microbiota Expertise Center in 2022 for in-depth microbial community analysis.
- Featured at major global events including EuroTier, VIV Asia, and SPACE France.
Phileo continues to push the boundaries of animal care through science, sustainability, and innovation—strengthening its role as a reliable global partner in the transition to antibiotic-free farming.